B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients-Reference-Cited by-同舟云学术

B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients

Published:2009-11 Issue:11 Volume:60 Page:3400-3409
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Hong Sandy D.,Reiff Andreas,Yang Hai-Tao,Migone Thi-Sau,Ward Christopher D.,Marzan Katherine,Shaham Bracha,Phei Wee Choo,Garza Judith,Bernstein Bram,Stohl William

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24902/fullpdf

Reference50 articles.

1. The role of B cells in lpr/lpr-induced autoimmunity;Shlomchik;J Exp Med,1994

2. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus;Chan;J Exp Med,1999

3. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N Engl J Med,2004

4. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator;Moore;Science,1999

5. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth;Schneider;J Exp Med,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus Nephritis in Children: Novel Perspectives;Medicina;2023-10-16

2. Belimumab for the treatment of pediatric patients with lupus nephritis;Expert Opinion on Biological Therapy;2023-02-17

3. B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?;Frontiers in Medicine;2022-04-04

4. Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus;Drugs in R&D;2021-10-09

5. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus;Clinical Therapeutics;2021-08